相关实验视频

Updated: Jul 25, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

免疫检查点抑制剂治疗肝细胞癌的当前景观

Samantha M Ruff¹, Ashish Manne², Jordan M Cloyd¹

¹Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Current oncology (Toronto, Ont.)

|June 27, 2023

概括

肝细胞癌 (HCC) 是一种肝癌,通常是晚诊断的. 像阿特佐利祖马布和贝瓦齐祖马布这样的免疫疗法组合显示,晚期HCC的存活率有所改善,这为新的希望提供了新的希望.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

肝脏的免疫微环境对于免疫耐受性和激活至关重要.
慢性炎症会破坏这种平衡,促进肝癌的进展.
肝细胞癌 (HCC) 经常发生在患有慢性肝病的患者中.

研究的目的:

为提供免疫检查点抑制剂 (ICI) 在HCC治疗中的概述.
突出ICI在克服瘤诱导的免疫耐受性方面的作用.
讨论先进的HCC系统治疗的最新进展.

主要方法:

关于HCC治疗和免疫治疗的当前文献的综述.
分析关键临床试验的研究结果,如IMbrave150.0.
解释免疫检查点抑制剂的作用机制.

主要成果:

与索拉费尼布相比,阿特佐利祖马布和贝瓦齐祖马布的组合在先进的HCC中显示出更高的生存结果.
现在,阿特佐利祖马布和贝瓦齐祖马布是推的第一线治疗方法,用于晚期的HCC.
ICI的功能是阻断抑制性免疫受体并增强抗瘤免疫力.

结论:

ICI代表了先进的HCC系统治疗的重大进展.
了解ICI机制是改善肝癌患者治疗结果的关键.
阿特佐利祖马布和贝瓦齐祖马布的组合为晚期HCC提供了一个有前途的治疗策略.

关键词:

肝硬化是肝硬化的一种疾病.肝细胞癌是肝细胞癌.免疫检查点抑制剂免疫检查点抑制剂免疫疗法免疫疗法肝脏肝脏肝脏肝脏肝脏肝脏

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...